The Role of the NOLUS Score in Predicting pCR and iDFS in HR-positive HER2-negative Early Breast Cancer Patients who Received Neoadjuvant Chemotherapy.

Cancer Diagn Progn · 2024 · PMC11534053 · PMID 39502621

Europe PMC DOI

hedged sentence

0.0643

closest p · 1.3× alpha

0.0643

boldest claim

The sentences

did not reach statistical significancep=0.0643so close (0.05 < p ≤ 0.1)

However, this difference did not reach statistical significance (p=0.0643).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.